date,title,source
Oct-22-18,Ovid Therapeutics Receives Company Making a Difference Award from CDKL5 Deficiency Disorder Community,GlobeNewswire
Oct-22-18,"Ovid Therapeutics to Host Conference Call and Webcast on Thursday, October 25, at 10:30 a.m. EDT",GlobeNewswire
Oct-25-18,Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65th AACAP Annual Meeting,GlobeNewswire
Nov-08-18,Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress,GlobeNewswire
